Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease

Am J Respir Crit Care Med. 2005 Dec 15;172(12):1510-6. doi: 10.1164/rccm.200504-595OC. Epub 2005 Sep 15.

Abstract

Rationale: Exacerbation of chronic obstructive pulmonary disease commonly causes hospitalization. The change in lung mechanics during exacerbation and its relationship to symptoms in spontaneously breathing individuals has not been described.

Objective: We hypothesized that changes in both airflow and lung volumes would occur during an exacerbation, but that only volume change would relate to symptomatic improvement.

Methods: Lung mechanics and resting dyspnea were recorded in 22 hospitalized patients during recovery from exacerbation.

Measurements: Spirometry, inspiratory capacity, respiratory system resistance and reactance, tidal breathing patterns, and expiratory flow limitation were recorded after nebulized bronchodilator therapy on the first 3 d after admission, at discharge, and 6 wk postadmission (Day 42). Prebronchodilator measurements were taken on Day 2, at discharge, and on Day 42.

Main results: Postbronchodilator inspiratory capacity increased 0.23 +/- 0.07 L by discharge and 0.42 +/- 0.1 L by Day 42, FEV1 rose 0.09 +/- 0.04 and 0.2 +/- 0.05 L at discharge and Day 42, respectively, and FVC increased 0.21 +/- 0.08 and 0.47 +/- 0.09 L at discharge and Day 42 (all p < 0.05). Consistent reduction in dyspnea was seen as the exacerbation resolved. Respiratory system resistance, FEV1/FVC, and expiratory flow limitation were unchanged throughout, indicating that changes in lung volume rather than airflow resistance predominated.

Conclusions: Improvement in operating lung volumes is the principal change seen as a chronic obstructive pulmonary disease exacerbation resolves and increase in inspiratory capacity is a useful guide to a reduction in dyspnea.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Airway Resistance
  • Bronchodilator Agents / therapeutic use
  • Dyspnea / drug therapy
  • Dyspnea / etiology
  • Dyspnea / physiopathology*
  • Female
  • Follow-Up Studies
  • Humans
  • Lung Volume Measurements
  • Male
  • Middle Aged
  • Prospective Studies
  • Pulmonary Disease, Chronic Obstructive / complications
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Pulmonary Disease, Chronic Obstructive / physiopathology*
  • Respiratory Mechanics / physiology*
  • Spirometry
  • Treatment Outcome

Substances

  • Bronchodilator Agents